The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
I initiate Rezolute (RZLT) with a hold rating, reflecting a balanced risk/reward amid significant clinical and regulatory ...
Outdated studies, misunderstood guidance, and the persistence of a safety claim the author says does not hold up.
BRONCHIECTASIS may silently increase risk of non-tuberculous mycobacteria infection, according to new genetic evidence.
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease controlAXPAXLI ...
India has slipped to the 6th-largest economy in the IMF's latest outlook. IndiaToday.in spoke to economists to understand why ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head studyFirst head-to-head, double-blind, ...
Mahmood’s interest in neuroscience led her to Indianapolis in summer 2025, where she helped with student research into early ...
IGHV mutational status has long been used by clinicians to predict how CLL will behave and when treatment may be needed. 2 ...
However, when adjusting for the presence of other pollutants, higher levels of hexachlorobenzene (HCB) in the blood were ...
Study reveals disparities in colorectal cancer treatment timeliness across urban, rural, and demographic groups. Read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results